These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 15184260

  • 1. Plasma adrenal androgens and risk of breast cancer in premenopausal women.
    Page JH, Colditz GA, Rifai N, Barbieri RL, Willett WC, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1032-6. PubMed ID: 15184260
    [Abstract] [Full Text] [Related]

  • 2. The association of plasma DHEA and DHEA sulfate with breast cancer risk in predominantly premenopausal women.
    Tworoger SS, Missmer SA, Eliassen AH, Spiegelman D, Folkerd E, Dowsett M, Barbieri RL, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):967-71. PubMed ID: 16702378
    [Abstract] [Full Text] [Related]

  • 3. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC).
    Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E.
    J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045
    [Abstract] [Full Text] [Related]

  • 4. Relationship of serum dehydroepiandrosterone (DHEA), DHEA sulfate, and 5-androstene-3 beta, 17 beta-diol to risk of breast cancer in postmenopausal women.
    Dorgan JF, Stanczyk FZ, Longcope C, Stephenson HE, Chang L, Miller R, Franz C, Falk RT, Kahle L.
    Cancer Epidemiol Biomarkers Prev; 1997 Mar 18; 6(3):177-81. PubMed ID: 9138660
    [Abstract] [Full Text] [Related]

  • 5. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, Hankinson SE.
    J Natl Cancer Inst; 2006 Oct 04; 98(19):1406-15. PubMed ID: 17018787
    [Abstract] [Full Text] [Related]

  • 6. Association between plasma prolactin concentrations and risk of breast cancer among predominately premenopausal women.
    Tworoger SS, Sluss P, Hankinson SE.
    Cancer Res; 2006 Feb 15; 66(4):2476-82. PubMed ID: 16489055
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women.
    Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2007 Jan 15; 16(1):161-4. PubMed ID: 17220346
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A prospective study of plasma total cysteine and risk of breast cancer.
    Zhang SM, Willett WC, Selhub J, Manson JE, Colditz GA, Hankinson SE.
    Cancer Epidemiol Biomarkers Prev; 2003 Nov 15; 12(11 Pt 1):1188-93. PubMed ID: 14652279
    [Abstract] [Full Text] [Related]

  • 16. Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk.
    Dorgan JF, Longcope C, Stephenson HE, Falk RT, Miller R, Franz C, Kahle L, Campbell WS, Tangrea JA, Schatzkin A.
    Cancer Epidemiol Biomarkers Prev; 1996 Jul 15; 5(7):533-9. PubMed ID: 8827358
    [Abstract] [Full Text] [Related]

  • 17. Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer.
    Helzlsouer KJ, Gordon GB, Alberg AJ, Bush TL, Comstock GW.
    Cancer Res; 1992 Jan 01; 52(1):1-4. PubMed ID: 1530765
    [Abstract] [Full Text] [Related]

  • 18. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status.
    Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, Orentreich N.
    Cancer Epidemiol Biomarkers Prev; 1998 Jun 01; 7(6):483-8. PubMed ID: 9641492
    [Abstract] [Full Text] [Related]

  • 19. Plasma prolactin concentrations and risk of postmenopausal breast cancer.
    Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE.
    Cancer Res; 2004 Sep 15; 64(18):6814-9. PubMed ID: 15375001
    [Abstract] [Full Text] [Related]

  • 20. Energy balance and breast cancer risk: a prospective cohort study.
    Silvera SA, Jain M, Howe GR, Miller AB, Rohan TE.
    Breast Cancer Res Treat; 2006 May 15; 97(1):97-106. PubMed ID: 16319973
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.